DiaMedica Therapeutics (NASDAQ:DMAC) Insider Buying and Selling Activity
Insider Ownership Percentage: 12.80%
DiaMedica Therapeutics (NASDAQ DMAC) Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 8/19/2019 | Scott Kellen | CFO | Buy | 3,000 | $2.43 | $7,290.00 | | |
| 8/16/2019 | Dietrich John Pauls | Insider | Buy | 1,000 | $2.68 | $2,680.00 | | |
| 8/16/2019 | Richard D Pilnik | Director | Buy | 7,840 | $2.56 | $20,070.40 | | |
| 5/31/2019 | Richard D Pilnik | Director | Buy | 19,000 | $2.80 | $53,200.00 | | |
| 5/24/2019 | Scott Kellen | CFO | Buy | 4,000 | $2.94 | $11,760.00 | | |
| 3/27/2019 | Harry W Alcorn Jr | Insider | Buy | 150 | $4.46 | $669.00 | | |
| 12/11/2018 | Harry W Alcorn Jr | Insider | Buy | 1,000 | $4.00 | $4,000.00 | | |
| 12/11/2018 | Randall Michael Giuffre | Director | Buy | 11,250 | $4.00 | $45,000.00 | | |
| 12/11/2018 | Scott Kellen | CFO | Buy | 1,250 | $4.00 | $5,000.00 | | |
(Data available from 1/1/2013 forward)
